...
首页> 外文期刊>Iranian Journal of Neurology >Hypothyroidism among patients with glioblastoma multiforme
【24h】

Hypothyroidism among patients with glioblastoma multiforme

机译:多形性胶质母细胞瘤患者甲状腺功能减退

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Patients with glioblastoma multiforme (GBM) are prone to various metabolic changes such as hypothyroidism. The present study was planned to assess the frequency of hypothyroidism in these patients. Methods: Fifty-two patients with GBM were included. All of them had been treated by tumor resection followed by cranial irradiation. Thyroid function was assessed by measurement of serum thyroid stimulating hormone (TSH), free thyroxin (FT4), and free triiodothyronine (FT3). Results: There were 33 men and 19 women. The average age was 52.4 ± 12.8 years. Among these, 32 (61%) had normal thyroid function test, whereas 4 (8%) had subclinical hypothyroidism, 5 (10%) had overt primary hypothyroidism, and 11 (21%) had secondary hypothyroidism. Sixteen patients (31%) needed thyroid hormone replacement therapy. Conclusion: Hypothyroidism is relatively prevalent in patients with treated GBM. Regular thyroid function test is advised to aid the introduction of appropriate hormone replacement therapy.
机译:背景:多形性胶质母细胞瘤(GBM)患者容易发生各种代谢变化,例如甲状腺功能减退。本研究计划评估这些患者甲状腺功能减退的频率。方法:纳入52例GBM患者。所有患者均已通过肿瘤切除,颅骨放射线治疗。通过测量血清甲状腺刺激激素(TSH),游离甲状腺素(FT4)和游离三碘甲状腺素(FT3)来评估甲状腺功能。结果:男33例,女19例。平均年龄为52.4±12.8岁。其中32例(61%)甲状腺功能检查正常,而4例(8%)患有亚临床甲状腺功能减退,5例(10%)患有明显的原发性甲状腺功能减退,11例(21%)患有继发性甲状腺功能减退。 16名患者(31%)需要甲状腺激素替代治疗。结论:甲状腺功能减退症在接受治疗的GBM患者中相对普遍。建议定期进行甲状腺功能检查,以帮助引入适当的激素替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号